Table 1 Pretreatment features of cases in the EP300-mutated poor response, EP300 wild-type poor response, and EP300 wild-type well response groups
Features | N | EP300 mutated poor response (N, %) | EP300 wild-type poor response (N, %) | EP300 wild-type well response (N, %) | P | ||
|---|---|---|---|---|---|---|---|
Age (years) | 0.179 | ||||||
≤ 60 | 10 (38.5) | 1 (25.0) | 1 (14.3) | 8 (53.3) | |||
>60 | 16 (61.5) | 3 (75.0) | 6 (85.7) | 7 (46.7) | |||
Gender | 0.223 | ||||||
Male | 20 (76.9) | 3 (75.0) | 7 (100) | 10 (66.7) | |||
Female | 6 (23.1) | 1 (25.0) | 0 (0) | 5 (33.3) | |||
Smoking history | 0.791 | ||||||
Yes | 17 (65.4) | 3 (75.0) | 5 (71.4) | 9 (60.0) | |||
No | 9 (34.6) | 1 (25.0) | 2 (28.6) | 6 (40.0) | |||
Alcohol consumption | 0.600 | ||||||
Yes | 16 (61.5) | 3 (75.0) | 5 (71.4) | 8 (53.3) | |||
No | 10 (38.5) | 1 (25.0) | 2 (28.6) | 7 (46.7) | |||
Site of ESCC | 0.228 | ||||||
up | 3 (11.5) | 0 (0) | 2 (28.6) | 1 (6.7) | |||
middle | 16 (61.5) | 2 (50.0) | 5 (71.4) | 9 (60.0) | |||
lower | 7 (26.9) | 2 (50.0) | 0 (0) | 5 (33.3) | |||
cT Stage | 0.239 | ||||||
2–3 | 23 (88.5) | 4 (100) | 5 (71.4) | 14 (93.3) | |||
4 | 3 (11.5) | 0 (0) | 2 (28.6) | 1 (6.7) | |||
cN Stage | 0.105 | ||||||
0–1 | 17 (65.4) | 3 (75.0) | 2 (28.6) | 12 (80.0) | |||
2 | 9 (34.6) | 1 (25.0) | 5 (71.4) | 3 (20.0) |